Merck
  • Home
  • Search Results
  • Effect of Topical 5-Aminoimidazole-4-carboxamide-1-β-d-Ribofuranoside in a Mouse Model of Experimental Dry Eye.

Effect of Topical 5-Aminoimidazole-4-carboxamide-1-β-d-Ribofuranoside in a Mouse Model of Experimental Dry Eye.

Investigative ophthalmology & visual science (2015-05-30)
Mi Sun Sung, Zhengri Li, Lian Cui, Ji Suk Choi, Won Choi, Min Jung Park, Soo Hyun Park, Kyung Chul Yoon
ABSTRACT

To investigate the efficacy of topical 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) in a mouse model of experimental dry eye (EDE). Eye drops consisting of 0.001% or 0.01% AICAR, 0.05% cyclosporine A (CsA), or balanced salt solution (BSS) were applied for the treatment of EDE. Tear volume, tear film break-up time (BUT), and corneal fluorescein staining scores were measured 10 days after treatment. Levels of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, interferon gamma-induced protein 10 (IP-10), and monokine induced by interferon-γ (MIG) were measured in the conjunctiva. In addition, Western blot, periodic acid-Schiff staining for evaluating goblet cell density, flow cytometry for counting the number of CD4+CXCR3+ T cells, and immunohistochemistry for detection of 4-hydroxy-2-nonenal (4HNE) were performed. Mice treated with 0.01% AICAR showed a significant improvement in all clinical parameters compared with the EDE control, vehicle control, and 0.001% AICAR groups (P < 0.001). A significant decrease in the levels of IL-1β, IL-6, TNF-α, IFN-γ, IP-10, and MIG, the number of CD4+CXCR3+ T cells, and the number of 4HNE-positive cells were also observed in the 0.01% AICAR group (P < 0.001). Although 0.05% CsA also led to an improvement in clinical parameters and inflammatory molecule levels, its therapeutic effects were comparable or inferior to those of 0.01% AICAR. Topical application of 0.01% AICAR can markedly improve clinical signs and decrease inflammation in the ocular surface of EDE, suggesting that AICAR eye drops may be used as a therapeutic agent for dry eye disease.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
塩化ナトリウム, BioXtra, ≥99.5% (AT)
Sigma-Aldrich
塩化ナトリウム, for molecular biology, DNase, RNase, and protease, none detected, ≥99% (titration)
Sigma-Aldrich
塩化ナトリウム 溶液, 5 M in H2O, BioReagent, for molecular biology, suitable for cell culture
Sigma-Aldrich
塩化ナトリウム, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
Sigma-Aldrich
塩化ナトリウム 溶液, 0.9% in water, BioXtra, suitable for cell culture
Sigma-Aldrich
塩化ナトリウム 溶液, 5 M
Sigma-Aldrich
塩化ナトリウム, meets analytical specification of Ph. Eur., BP, USP, 99.0-100.5%
Sigma-Aldrich
塩化ナトリウム, JIS special grade, ≥99.5%
Sigma-Aldrich
塩化ナトリウム, BioUltra, for molecular biology, ≥99.5% (AT)
Sigma-Aldrich
AICAR, ≥98% (HPLC), powder
Sigma-Aldrich
塩化ナトリウム 溶液, 0.85%
Sigma-Aldrich
塩化ナトリウム 溶液, BioUltra, for molecular biology, ~5 M in H2O
Sigma-Aldrich
スコポラミン 臭化水素酸塩, meets USP testing specifications
Sigma-Aldrich
塩化ナトリウム, 99.999% trace metals basis
Sigma-Aldrich
(−)-スコポラミン 臭化水素酸塩 三水和物, ≥98% (HPLC), powder
Sigma-Aldrich
塩化ナトリウム, BioPerformance Certified, ≥99% (titration), suitable for insect cell culture, suitable for plant cell culture
Sigma-Aldrich
塩化ナトリウム, SAJ first grade, ≥99.0%
Sigma-Aldrich
塩化ナトリウム, tablet
Sigma-Aldrich
塩化ナトリウム, AnhydroBeads, −10 mesh, 99.999% trace metals basis
Sigma-Aldrich
塩化ナトリウム 溶液, 1 M
Sigma-Aldrich
塩化ナトリウム, random crystals, optical grade, 99.9% trace metals basis
Sigma-Aldrich
塩化ナトリウム, AnhydroBeads, −10 mesh, 99.99% trace metals basis
Sigma-Aldrich
塩化ナトリウム 溶液, 0.1 M
Sigma-Aldrich
塩化ナトリウム-35Cl, 99 atom % 35Cl